Literature DB >> 10823759

Disease progression and survival with human immunodeficiency virus type 1 subtype E infection among female sex workers in Thailand.

P H Kilmarx1, K Limpakarnjanarat, J Kaewkungwal, R Srismith, S Saisorn, W Uthaivoravit, N L Young, T D Mastro.   

Abstract

This study describes rates and correlates of disease progression and survival among 194 female sex workers in northern Thailand who were infected with human immunodeficiency virus type 1 (HIV-1; 96% with subtype E). The median rate of CD4 T lymphocyte decline (3.9 cells/microL/month), median time from infection to <200 CD4 T lymphocytes/microL (6.9 years), and time to 25% mortality (6.0 years) were similar to those found in studies performed in Western countries before highly active antiretroviral therapy was available to populations infected with HIV-1 subtype B. Mortality rates among women with >100,000 HIV-1 RNA copies/mL were 15.4 times higher (95% confidence interval, 5.2-45.2) than among women with <10,000 copies. Initial CD4 T lymphocyte counts and serum virus load were independently strong predictors of survival. These results can help in assessing the effects of the epidemic in Thailand and in determining the prognoses for individual patients.

Entities:  

Mesh:

Year:  2000        PMID: 10823759     DOI: 10.1086/315469

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  11 in total

1.  Progression to symptomatic disease in people infected with HIV-1 in rural Uganda: prospective cohort study.

Authors:  Dilys Morgan; Cedric Mahe; Billy Mayanja; James A G Whitworth
Journal:  BMJ       Date:  2002-01-26

2.  Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe.

Authors:  Charles S Morrison; Pai-Lien Chen; Immaculate Nankya; Anne Rinaldi; Barbara Van Der Pol; Yun-Rong Ma; Tsungai Chipato; Roy Mugerwa; Megan Dunbar; Eric Arts; Robert A Salata
Journal:  J Acquir Immune Defic Syndr       Date:  2011-06-01       Impact factor: 3.731

3.  Associations of hormonal contraceptive use with measures of HIV disease progression and antiretroviral therapy effectiveness.

Authors:  Maura K Whiteman; Gary Jeng; Anna Samarina; Natalia Akatova; Margarita Martirosyan; Dmitry M Kissin; Kathryn M Curtis; Polly A Marchbanks; Susan D Hillis; Michele G Mandel; Denise J Jamieson
Journal:  Contraception       Date:  2015-07-18       Impact factor: 3.375

Review 4.  Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643

Review 5.  Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysis.

Authors:  Elisa Mountain; Sharmistha Mishra; Peter Vickerman; Michael Pickles; Charles Gilks; Marie-Claude Boily
Journal:  PLoS One       Date:  2014-09-29       Impact factor: 3.240

Review 6.  Minimizing fungal disease deaths will allow the UNAIDS target of reducing annual AIDS deaths below 500 000 by 2020 to be realized.

Authors:  David W Denning
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2016-12-05       Impact factor: 6.237

7.  Antiviral inhibitory capacity of CD8+ T cells predicts the rate of CD4+ T-cell decline in HIV-1 infection.

Authors:  Hongbing Yang; Hao Wu; Gemma Hancock; Genevieve Clutton; Nellia Sande; Xiaoning Xu; Huiping Yan; Xiaojie Huang; Brian Angus; Kristin Kuldanek; Sarah Fidler; Thomas N Denny; Jacqueline Birks; Andrew McMichael; Lucy Dorrell
Journal:  J Infect Dis       Date:  2012-06-18       Impact factor: 5.226

8.  Time from HIV seroconversion to death: a collaborative analysis of eight studies in six low and middle-income countries before highly active antiretroviral therapy.

Authors:  Jim Todd; Judith R Glynn; Milly Marston; Tom Lutalo; Sam Biraro; Wambura Mwita; Vinai Suriyanon; Ram Rangsin; Kenrad E Nelson; Pam Sonnenberg; Dan Fitzgerald; Etienne Karita; Basia Zaba
Journal:  AIDS       Date:  2007-11       Impact factor: 4.177

9.  Duration from seroconversion to eligibility for antiretroviral therapy and from ART eligibility to death in adult HIV-infected patients from low and middle-income countries: collaborative analysis of prospective studies.

Authors:  Simon Wandel; Matthias Egger; Ram Rangsin; Kenrad E Nelson; Caroline Costello; Charlotte Lewden; Tom Lutalo; Anthony Ndyanabo; Jim Todd; Lieve Van der Paal; Albert Minga; Marcel Zwahlen
Journal:  Sex Transm Infect       Date:  2008-08       Impact factor: 3.519

10.  CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time.

Authors:  Anne Cori; Michael Pickles; Ard van Sighem; Luuk Gras; Daniela Bezemer; Peter Reiss; Christophe Fraser
Journal:  AIDS       Date:  2015-11-28       Impact factor: 4.177

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.